Erik Severson, MD
Orthopaedic Surgery · Crosby, MNNPI 1801082854
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $89,411 of the $95,929 with a category attached, or 93.2%. Medical Device Business Services, Inc. accounts for 96.6% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $26,146 and has fallen 83.1% since, to $4,411 in 2025. Among orthopaedic surgery clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 80 payments — averaging $1199.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$93K
- Johnson & Johnson$3K
- Acell, Inc.$95
- Smith+Nephew$81
Across 10 payments — averaging $18,797 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$188K
What the payments were for
- Consulting fees$89,41193%
- Travel & lodging$4,7505%
- Food & beverage$1,7682%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 55 | $92,683 |
| Johnson & Johnson(2 entities) | 23 | $3,071 |
| Acell, Inc. | 1 | $95 |
| Smith+Nephew | 1 | $81 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Velys$82,031
- VELYS Hip Navigation$9,142
- ACTIS$943
- ATTUNE$943
How this compares
$95,929 in reported general payments places this provider in the 90th percentile of 533 orthopaedic surgery providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CeftriaxoneCeftriaxone Sodium | 15 | $270 |
| Methocarbamol | 27 | $120 |
| Meloxicam | 23 | $105 |
| Amoxicillin | 17 | $100 |
| Tamsulosin Hcl | 18 | $56 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Crosby
- James StokmanCrosby$90K
- Daniel BerryRochester$21.5M
- Mark PagnanoRochester$14.8M
- Robert TrousdaleRochester$12.2M
- John SperlingRochester$12.2M
- Shawn O'DriscollRochester$10.5M
- Bryan Den HartogStillwater$9M
- Joseph NesslerSartell$8.6M
- David LewallenRochester$8M
- Rafael SierraRochester$4.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.